by Prateek Chopra | May 14, 2026 | Cardiology Conferences | ESC-HF 2026 Heart failure phenotypes characterized by improvement or recovery in le ventricular ejec on frac on (LVEF) have emerged as important clinical en es, leading to the evolving concepts of heart failure with improved ejec on frac on (HFimpEF), heart failure with recovered heart failure (HFrecHF/HFrecEF), and heart failure […]
What are HFimpEF, HFrecHF, and HFremEF? Read Post »
by Prateek Chopra | June 20, 2026 | Cardiology Conferences | ESH 2026 Study Background: Despite established guidelines, hypertension remains poorly controlled globally, particularly in primary care. Barriers to guideline implementation include structural, behavioral, and communication challenges across healthcare systems. This session outlined practical strategies to transform everyday hypertension management using insights from clinicians across Europe. Methodology & Framework: Key Insights:
Clinical Practice Update – What Should We Do Di erently Now Read Post »
by Prateek Chopra | June 10, 2026 | Cardiology Conferences | ESH 2026 Context and Rationale: Single-pill triple low-dose combination (triple-LDC) antihypertensive therapies have emerged as an alternative initial treatment strategy, expanding options beyond conventional monotherapy. The therapy aims to improve BP control while minimizing adverse effects by using ≤50% of standard doses for each component. Study Design: Trial Population and
by Prateek Chopra | June 9, 2026 | Cardiology Conferences | ESH 2026 Enhanced Adherence and Persistence: Blood Pressure Reduction: Cardiovascular Outcomes & Mortality: Real-World Cost and Implementation: Single-pill combinations represent an effective, evidence-based, and cost-efficient strategy for hypertension management. They consistently improve adherence, accelerate BP control, reduce cardiovascular and stroke events, and lower healthcare costs compared with free-drug combinations, supporting
From Guidelines to Adherence – Driven Outcomes: The Value of SPCs Read Post »
by Prateek Chopra | June 8, 2026 | Cardiology Conferences | ESH 2026 Simplifying Hypertension Care: Despite hypertension being a leading contributor to cardiovascular morbidity and mortality, BP control remains suboptimal due to poor adherence, therapeutic inertia, and complex multi-drug regimens. Triple single-pill combinations (SPCs) simplify therapy, improve adherence, accelerate BP target attainment, and enhance long-term cardiovascular outcomes. Guideline-Based Recommendations: Real-World
Triple SPCs: Simplifying Treatment, Strengthening Control Read Post »
